Research / ESCA / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-22-003913 General Corporate
Debt relative to revenue 61th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.debt_to_revenue
18.35% · OPTIONAL · VALID
Capex intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.09% · OPTIONAL · VALID
Operating cash generation 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.30% · OPTIONAL · VALID
Revenue growth 70th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
14.60% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
29.46% · OPTIONAL · VALID
Operating margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
10.17% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.64% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.29% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 46 states Self-history eligible
Mar 19, 2022 7/7 normalized Level 3 Jul 9, 2022 7/7 normalized Level 3 Oct 1, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Amended as filed Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Amended as filed Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 72.59%
Current 18.35%
Delta -54.25% Capex Intensity Decreased
Previous 4.92%
Current 3.09%
Delta -1.83% Cash Generation Increased
Previous -3.14%
Current 0.30%
Delta 3.44% Growth Increased
Previous -5.89%
Current 14.60%
Delta 20.49% Inventory Pressure Decreased
Previous 112.86%
Current 29.46%
Delta -83.41% Profitability Increased
Previous 9.44%
Current 10.17%
Delta 0.73% Sbc Intensity Increased
Previous 0.28%
Current 0.29%
Delta 0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.